Conjunctivitis News and Research

RSS
Conjunctivitis is an eye infection that may cause redness and discharge from the eye, sometimes with pain or itching. It can be caused by bacteria or viruses.
FDA grants three years of marketing exclusivity to ISTA's BROMDAY

FDA grants three years of marketing exclusivity to ISTA's BROMDAY

Millions of Americans suffer unnecessarily with itchy, gritty, watery eyes, say allergists

Millions of Americans suffer unnecessarily with itchy, gritty, watery eyes, say allergists

Teva presents QNAZE Phase III study results for SAR at ACAAI Meeting

Teva presents QNAZE Phase III study results for SAR at ACAAI Meeting

NovaBay third quarter net loss increases to $1.6 million

NovaBay third quarter net loss increases to $1.6 million

bitop includes first patient in Ectoin inhalation solution clinical trial for inflammation and airway obstruction

bitop includes first patient in Ectoin inhalation solution clinical trial for inflammation and airway obstruction

Inspire third quarter net loss decreases to $7.6 million

Inspire third quarter net loss decreases to $7.6 million

QLT third quarter sales decreases 12.9% to $20.5 million

QLT third quarter sales decreases 12.9% to $20.5 million

ISTA third quarter net revenue increases 31% to $42.0 million

ISTA third quarter net revenue increases 31% to $42.0 million

Allergan third quarter diluted loss per share increases to $2.21

Allergan third quarter diluted loss per share increases to $2.21

Fever, diarrhoea or vomiting do not prevent British parents from sending children to school

Fever, diarrhoea or vomiting do not prevent British parents from sending children to school

NovaBay delivers two poster presentations on Aganocide compounds at IDSA Annual Meeting

NovaBay delivers two poster presentations on Aganocide compounds at IDSA Annual Meeting

Inspire presents data on denufosol therapy for cystic fibrosis at NACFC conference

Inspire presents data on denufosol therapy for cystic fibrosis at NACFC conference

Alcon concludes 'proof of concept' clinical trial of NovaBay's Aganocide for viral conjunctivitis treatment

Alcon concludes 'proof of concept' clinical trial of NovaBay's Aganocide for viral conjunctivitis treatment

FDA approves ISTA's sNDA for BROMDAY ophthalmic anti-inflammatory drug

FDA approves ISTA's sNDA for BROMDAY ophthalmic anti-inflammatory drug

NovaBay to present two poster presentations at IDSA Annual Meeting

NovaBay to present two poster presentations at IDSA Annual Meeting

NanoViricides files financial year end annual report with SEC

NanoViricides files financial year end annual report with SEC

Ocular Therapeutix completes Proof of Principle clinical study with moxifloxacin punctum plug

Ocular Therapeutix completes Proof of Principle clinical study with moxifloxacin punctum plug

ISTA Pharmaceuticals announces Phase 1/2 clinical study results of bepotastine besilate nasal spray

ISTA Pharmaceuticals announces Phase 1/2 clinical study results of bepotastine besilate nasal spray

REMURA Phase 2 clinical study results highlighted at Tear Film & Ocular Surface conference

REMURA Phase 2 clinical study results highlighted at Tear Film & Ocular Surface conference

Annals of Internal Medicine publishes GRACE study data on HIV therapy

Annals of Internal Medicine publishes GRACE study data on HIV therapy